Your browser doesn't support javascript.
loading
Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington's Disease: A Survey Conducted by the European Huntington Association.
Júlio, Filipa; Blanco, Ruth; Casanova, Josè Perez; D'Alessio, Barbara; De Schepper, Beatrice; De Sousa, Dina; De Sousa, Paul; Ferreira, Cristina; Gommans, Hans; Haselberg, Rob; Hermant, Emilie; Lis, Danuta; Maffi, Sabrina; Olsen, Svein Olaf; Papantoniou, Marios; Squitieri, Ferdinando; Tretyakova, Marina; Umakhanova, Zaynab; Václavík, Vladimír; Winkelmann, Michaela; Arnesen, Astri.
Affiliation
  • Júlio F; European Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
  • Blanco R; Associação Portuguesa dos Doentes de Huntington, Praça António Baião, nº. 7 loja A, 1500-567 Lisboa, Portugal.
  • Casanova JP; European Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
  • D'Alessio B; Asociación Corea de Huntington Española, Avenida Cardenal Herrera Oria 80B, C.P. 28034 Madrid, Spain.
  • De Schepper B; European Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
  • De Sousa D; Asociación Corea de Huntington Española, Avenida Cardenal Herrera Oria 80B, C.P. 28034 Madrid, Spain.
  • De Sousa P; European Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
  • Ferreira C; Fondazione Lega Italiana Ricerca Huntington, Via Varese 31, 00185 Rome, Italy.
  • Gommans H; European Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
  • Haselberg R; Huntington Liga, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
  • Hermant E; European Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
  • Lis D; Scottish Huntington's Association, Business First, Linwood Point, Paisley PA1 2FB, UK.
  • Maffi S; European Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
  • Olsen SO; Scottish Huntington's Association, Business First, Linwood Point, Paisley PA1 2FB, UK.
  • Papantoniou M; European Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
  • Squitieri F; Associação Portuguesa dos Doentes de Huntington, Praça António Baião, nº. 7 loja A, 1500-567 Lisboa, Portugal.
  • Tretyakova M; European Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
  • Umakhanova Z; Vereniging Van Huntington, Stationsplein 125, 3818 LE Amersfoort, The Netherlands.
  • Václavík V; European Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
  • Winkelmann M; Vereniging Van Huntington, Stationsplein 125, 3818 LE Amersfoort, The Netherlands.
  • Arnesen A; European Huntington Association, Spelonckvaart 30, 9180 Moerbeke (Waas), Belgium.
  • On Behalf Of The European Huntington Association; L'Association Huntington France, 44, rue du Château des Rentiers, 75013 Paris, France.
J Pers Med ; 11(8)2021 Aug 20.
Article in En | MEDLINE | ID: mdl-34442459
ABSTRACT
There has been great progress in Huntington's disease (HD) research. Yet, effective treatments to halt disease before the onset of disabling symptoms are still unavailable. Scientific breakthroughs require an active and lasting commitment from families. However, they are traditionally less involved and heard in studies. Accordingly, the European Huntington Association (EHA) surveyed individuals at risk (HDRisk) and with premanifest HD (PreHD) to determine which factors affect their willingness to participate in research. Questions assessed research experience and knowledge, information sources, reasons for involvement and noninvolvement, and factors preventing and facilitating participation. The survey included 525 individuals, of which 68.8% never participated in studies and 38.6% reported limited research knowledge. Furthermore, 52% trusted patient organizations to get research information. Reasons for involvement were altruistic and more important than reasons for noninvolvement, which were related to negative emotions. Obstacles included time/financial constraints and invasive procedures, while professional support was seen as a facilitator. PreHD individuals reported less obstacles to research participation than HDRisk individuals. Overall, a high motivation to participate in research was noted, despite limited experience and literacy. This motivation is influenced by subjective and objective factors and, importantly, by HD status. Patient organizations have a key role in fostering motivation through education and support.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: J Pers Med Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: J Pers Med Year: 2021 Document type: Article Affiliation country: